Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes ...

To reduce elevated intraocular pressure (IOP) in glaucoma or ocular hypertension where adjunctive or replacement therapy is warranted. Combigan contains two drugs widely used in the treatment of ...

Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

A Support, Educate, Empower (SEE) glaucoma coaching program improves medication adherence compared with standard written education, according to a study published online Feb. 26 in JAMA Ophthalmology.

WASHINGTON (Reuters) - For the first time in 20 years, patients suffering from the eye disease glaucoma may soon have new treatments as several young companies look to shake up the $5.6 billion global ...

Use of GLP-1 receptor agonists for obesity was tied to a reduced risk of glaucoma versus other weight-loss drugs. The findings were in line with those of a previous study that included patients ...

Artelo Biosciences Inc (NASDAQ:ARTL) shares jumped 32.9% Wednesday following the company’s announcement of a study agreement with Belfast Health and Social Care Trust to evaluate its drug candidate ...

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in ...

Glaucoma often progresses silently, damaging vision before you even notice a problem. Experts warn that believing common myths can delay diagnosis and increase the risk of irreversible blindness.

Building on prior Ophthalmology Times coverage examining how ophthalmic drug shortages are both more frequent and longer-lasting than the national average, Ian Pitha, MD, PhD, an ophthalmologist at ...

WASHINGTON (Reuters) - Glaucoma drugs appear to reduce the likelihood of death among patients using them compared with those patients receiving no treatment but it is not clear why, U.S. researchers ...

Using zebrafish and mice, scientists from the University of Cambridge have shown that a common glaucoma drug might be able to protect the brain from the buildup of tau protein, which has been ...